View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
February 26, 2015

Scripps Health opens new $456m Prebys Cardiovascular Institute in US

US-based health care system Scripps Health has opened a new $456m Prebys Cardiovascular Institute in La Jolla of San Diego, California, US.

Prebys

US-based health care system Scripps Health has opened a new $456m Prebys Cardiovascular Institute in La Jolla of San Diego, California, US.

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

Located on the campus of Scripps Memorial Hospital La Jolla, the 383,000ft² and seven-storey centre above Genesee Avenue is named for Conrad Prebys, a real estate developer who donated $45m for the project.

Scripps Health president Chris Van Gorder said: "Today, we celebrate the opening of one of the country’s top cardiovascular institutes right here in San Diego, which offers the most advanced heart care available not just for patients in our community but for heart patients everywhere.

"We designed this institute to be centred around our patients and their needs, creating an innovative environment for collaboration among some of the nation’s most brilliant physicians, for ground-breaking research by world-class scientists, and for the diagnosis and treatment of the most challenging heart conditions."

"The new tower includes 108 inpatient beds in private rooms, 59 intensive care beds, six modern operating rooms, and three advanced technology cardiac catheterisation labs."

The new tower includes 108 inpatient beds in private rooms, 59 intensive care beds, six modern operating rooms, and three advanced technology cardiac catheterisation labs.

Work has started for the new emergency department on the ground floor of the hospital, which is expected to commence operations in June 2016.

The new hospital features decentralised nurse stations to closely monitor patients and communicate with family members, and two hybrid operating rooms for catheterisation procedures or surgeries.

In addition, the centre features 17 negative pressure isolation rooms, and private rooms equipped with LCD screen televisions that can display clinical images such as CT scans.

Scripps Clinic John R Anderson V Medical Pavilion, a $130m multispecialty medical building, is being built adjacent to the institute. It is expected to be operational in March 2016.


Image: Scripps Health has opened new Prebys Cardiovascular Institute. Photo: courtesy of 2015 Scripps Health San Diego.

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management